High affinity allele for the gene of FCGR3A is risk factor for HIV infection and progression

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Poonia, Bhawna ^a   Kijak, Gustavo H ^b   Pauza, C David ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIIA; UNCLASSIFIED DRUG; FCGR2A PROTEIN, HUMAN; FCGR3A PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOREACTIVITY; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; ALLELE; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; RISK FACTOR; VIROLOGY;

ALLELES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HIV INFECTIONS; HOMOZYGOTE; HUMANS; MALE; RECEPTORS, IGG; RISK FACTORS;

EID: 78650919403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015562     Document Type: Article

References (16)

1. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
2. Suzuki T, Ishii-Watabe A, Tada M, Kobayashi T, Kanayasu-Toyoda T, et al. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J Immunol 184: 1968-1976.
3. Hussain LA, Kelly CG, Fellowes R, Hecht EM, Wilson J, et al. (1992) Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin Exp Immunol 90: 530-538.
4. Hussain LA, Kelly CG, Hecht EM, Fellowes R, Jourdan M, et al. (1991) The expression of FC receptors for immunoglobulin G in human rectal epithelium. AIDS 5: 1089-1094.
5. Ozturk C, Aksu G, Berdeli A, Kutukculer N (2006) Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases. Clin Exp Med 6: 27-32.
6. Thabet MM, Huizinga TW, Marques RB, Stoeken-Rijsbergen G, Bakker AM, et al. (2009) Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis 68: 1775-1780.
7. Bibeau F, Lopez-Crapez E, Di Fiore F, Thezenas S, Ychou M, et al. (2009) Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. J Clin Oncol 27: 1122-1129.
8. Kim DH, Jung HD, Kim JG, Lee JJ, Yang DH, et al. (2006) FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood 108: 2720-2725.
9. Sajadi MM, Heredia A, Le N, Constantine NT, Redfield RR (2007) HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. AIDS 21: 517-519.
10. Lehrnbecher T, Foster CB, Zhu S, Leitman SF, Goldin LR, et al. (1999) Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 94: 4220-4232.
11. Lehrnbecher TL, Foster CB, Zhu S, Venzon D, Steinberg SM, et al. (2000) Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men. Blood 95: 2386-2390.
12. Forthal DN, Landucci G, Bream J, Jacobson LP, Phan TB, et al. (2007) FcgammaRIIa genotype predicts progression of HIV infection. J Immunol 179: 7916-7923.
13. Brouwer KC, Lal RB, Mirel LB, Yang C, van Eijk AM, et al. (2004) Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 18: 1187-1194.
14. Forthal DN, Gilbert PB, Landucci G, Phan T (2007) Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 178: 6596-6603.
15. Fontenot D, He H, Hanabuchi S, Nehete PN, Zhang M, et al. (2009) TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc Natl Acad Sci U S A 106: 16776-16781.
16. Povolotsky J, Gold JW, Chein N, Baron P, Armstrong D (1991) Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions. J Infect Dis 163: 247-251.